Background There has been a rise in explosive onset of tic-like behaviors during the COVID-
19 pandemic. Historically, this is an uncommon phenomenology of functional movement …

Perceptions of Tourette syndrome (TS) and tic disorders are often driven by social media.
During the COVID-19 pandemic, social media consumption greatly increased, particularly in …

Background and purpose Core clinical manifestations of COVID‐19 include influenza‐like
and respiratory symptoms. However, it is now evident that neurological involvement may …

As the world continues to experience the effects of SARS‐CoV‐2, there is evidence to
suggest that the sequelae of viral infection (the post‐COVID‐19 condition; PCC) at both an …

Background Neurological symptoms are common manifestation in acute COVID-19. This
includes hyper-and hypokinetic movement disorders. Data on their outcome, however, is …

Ultraviolet (UV) light can inactivate SARS-CoV-2. However, the practicality of UV light is
limited by the carcinogenic potential of mercury vapor-based UV lamps. Recent advances in …

Abstract Purpose of Review Both traumatic and acquired brain injury can result in diffuse
multifocal injury affecting both the pyramidal and extrapyramidal tracts. Thus, these patients …

The neurological symptoms of long COVID and viral neuroinvasion have raised concerns
about the potential interactions between SARS-CoV-2 protein segments and neuronal …

Background Neurological manifestations frequently occur in individuals with COVID-19,
manifesting during the acute phase, persisting beyond the resolution of acute symptoms …

Agomelatine (AGM) is one of the latest atypical antidepressants, prescribed exclusively for
the treatment of depression in adults. AGM belongs to the pharmaceutical class of melatonin …